R&D Systems Inc. Tocris Bioscience Boston Biochem

1-Naphthyl PP1

Cat. No. 3063

1-Naphthyl PP1 C19H19N5 [221243-82-9]

Price and Availability

For 1-Naphthyl PP1 pricing & availability please select your country from the drop down menu:
Submit
By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Alternative Name: 1-NA-PP 1

Chemical Name: 1-(1,1-Dimethylethyl)-3-(1-naphthal­enyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Biological Activity

Selective inhibitor of src family kinases v-Src and c-Fyn as well as the tyrosine kinase c-Abl. (IC50 values are 1.0, 0.6, 0.6, 18 and 22 μM for v-Src, c-Fyn, c-Abl, CDK2 and CAMK II respectively). Preferentially inhibits mutant over wild-type kinases (IC50 values are 1.5 vs 1000 nM for I338G v-src and v-src respectively).

Technical Data

M.Wt:
317.39
Formula:
C19H19N5
Solubility:
Soluble to 50 mM in DMSO
Purity:
>99 %
Storage:
Store at +4°C
CAS No:
221243-82-9

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch
Safety Data Sheet: View Safety Data Sheet

References

Bishop et al (1999) Generation of monospecific nanomolar tyrosine kinase inhibitors via a chemical genetic approach. J.Am.Chem.Soc. 121 627.

Bishop et al (2000) A chemical switch for inhibitor-sensitive alleles of any protein kinase. Nature 407 395. PMID: 11014197.

If you know of a relevant citation for this product please let us know.

View Related Products by Target

Keywords: 1-Naphthyl PP1, supplier, Src, family, kinase, inhibits, inhibitors, c-Abl, v-Src, c-Fyn, 1-NaphthylPP1, 1NAPP1

Quick Order

Find multiple products by catalog number

divider line

Cancer Research Guide

Request your free copy

Cancer Research Guide

Highlights over 350 products for cancer research. Request a copy or view PDF today.

divider line

Kinases Product Listing

Kinases Product Listing

Highlights over 350 products for kinase research. Request a copy or view PDF today.

divider line

Kinase Inhibitor Toolbox

80 Kinase inhibitors
pre-dissolved in DMSO

Some of the most potent
kinase inhibitors all on one plate

Includes many of the latest kinase inhibitors to become commercially available. Covers a wide range of kinase targets including EGFR, MAPK and CDK.

divider line

Immunology Guide

Immunology Research Guide

Highlights over 150 products for immunology research. Request a copy or view PDF today.

divider line

New Product Guide

NPG

Highlights over 130 new products added in 2012. Request a copy or view PDF today.

divider line

New Products in this Area

Flavopiridol hydrochloride

Cyclin-dependent kinase inhibitor

GSK2578215A

Potent, selective LRRK2 inhibitor; brain penetrant

Amlexanox

Inhibitor of TBK1 and IKKε; antiallergic agent

PF 05212384

Potent and selective dual PI 3-kinase/mTOR inhibitor

PF 03814735

Aurora kinase A and B inhibitor

PF 04691502

Dual PI 3-K/mTOR inhibitor

TNP

Inhibitor of IP6K; also inhibits IP3K

ACHP

Selective IKKα and IKKβ inhibitor

PD 0332991 isethionate

Potent, selective Cdk4/6 inhibitor; brain penetrant

CZC 24832

Selective inhibitor of PI 3-Kinase γ

LY 333531 hydrochloride

Protein kinase C inhibitor; selective for β isozymes

PF 06465469

Potent inhibitor of interleukin-2 inducible T cell kinase (ITK). Also inhibits BTK

10Z-Hymenialdisine

Pan kinase inhibitor; potently inhibits MEK-1

CP 690550 citrate

Potent JAK inhibitor

WYE 687 dihydrochloride

Potent and selective mTOR inhibitor

N,N-Dimethylsphingosine

Sphingosine kinase inhibitor

PEP 005

Protein kinase C activator

CZC 54252 hydrochloride

Potent LRRK2 inhibitor; neuroprotective

Bisindolylmaleimide II

Potent PKC inhibitor and nicotinic receptor antagonist

CID 2011756

Pan protein kinase D (PKD) inhibitor; cell permeable

Sign-up for new product e-alerts
divider line

Tocris Events

Meet your representative

R&D Symposium 2013

The Role of Cytokines and Signaling in Inflammation

October 15, 2013

Bonn, Germany